Biodel Inc. (BIOD) Announces Development Plans to Commercialize Glucagon Rescue Product Candidate for the Treatment of Severe Hypoglycemia
6/6/2013 9:35:40 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
DANBURY, Conn., June 6, 2013 (GLOBE NEWSWIRE) -- Biodel Inc. (Nasdaq:BIOD) today announced plans to submit a New Drug Application (NDA) to the FDA in 2015 for a novel glucagon rescue device to treat severe hypoglycemia.
Help employers find you! Check out all the jobs and post your resume.
comments powered by